Strata Critical Medical Income Statement (2019-2025) | SRTA

Income Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 3.44M8.32M9.27M12.95M20.32M24.62M26.63M35.63M45.72M38.13M45.27M60.99M71.44M47.48M51.51M67.94M36.06M138.26M54.31M70.80M49.30M
Cost of Revenue 7.80M9.98M15.86M20.68M23.71M30.52M36.46M33.16M38.11M50.62M55.86M38.47M41.38M51.59M28.55M103.92M42.33M53.06M37.68M
Gross Profit 1.48M2.98M4.46M3.94M2.92M5.11M9.27M4.97M7.16M10.37M15.58M9.01M10.14M16.35M7.51M34.34M11.98M17.74M11.61M
Operating items
Research & Development 0.22M0.17M0.29M0.32M0.84M0.70M0.83M1.06M2.03M1.62M1.12M1.44M1.08M0.99M0.67M0.97M0.42M2.15M0.81M0.92M0.45M
Selling, General & Administrative 1.56M1.92M4.83M9.81M12.12M12.39M13.98M12.14M15.81M20.58M16.26M18.41M19.27M41.24M17.21M25.14M13.87M42.57M17.31M20.14M16.30M
Other Operating Expenses 0.04M0.90M0.15M3.13M-1.93M8.38M10.59M17.09M22.06M25.51M32.16M38.31M35.62M40.72M53.35M58.55M40.88M43.50M53.99M28.87M110.84M43.76M54.70M38.17M
Operating Expenses 0.04M0.90M0.15M4.91M0.16M13.50M20.72M30.05M35.15M40.32M45.37M56.15M57.81M58.10M73.20M78.89M83.11M61.38M80.09M43.15M155.57M61.89M75.75M54.92M
Operating Income -0.04M-0.90M-0.15M-1.48M-0.16M-4.22M-7.77M-9.73M-10.54M-13.69M-9.73M-10.43M-19.68M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-17.30M-7.58M-4.95M-5.62M
EBIT -0.04M-0.90M-0.15M-1.48M-0.16M-4.22M-7.77M-9.73M-10.54M-13.69M-9.73M-10.43M-19.68M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-17.30M-7.58M-4.95M-5.62M
Non-operating items
Non Operating Investment Income -0.14M
Interest & Investment Income 0.17M1.26M0.87M0.11M0.03M0.00M2.08M2.15M2.26M2.07M1.79M1.76M1.59M1.32M1.16M1.13M
Non Operating Income 0.17M5.99M0.15M0.02M0.00M-16.52M-3.10M11.20M2.68M18.14M1.24M3.44M2.44M-0.40M7.87M0.67M5.55M0.88M1.47M-1.53M4.07M1.23M-4.04M
Net income details
EBT 0.12M2.54M5.85M-0.01M-0.13M-1.08M-7.77M-12.83M0.66M-11.01M8.41M-9.19M-16.24M-10.39M-12.61M0.42M-34.96M-4.32M-11.27M-5.63M-18.83M-3.51M-3.72M-9.66M
Tax Provisions 0.03M0.21M0.15M-0.00M-0.03M-3.64M-0.11M0.06M-0.83M-0.20M-0.38M0.13M-1.02M-0.08M0.05M-0.26M-0.02M0.02M
Profit After Tax 0.10M2.33M5.70M-1.32M-0.10M-4.22M-24.29M-9.18M0.77M-11.01M8.41M-9.24M-27.26M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M-5.63M-9.79M-3.49M-3.74M57.42M
Income from Continuing Operations 0.10M2.33M5.70M-0.01M-0.10M-1.08M-7.77M-9.18M0.77M-11.01M8.41M-9.24M-15.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M-5.63M-18.58M-3.49M-3.74M-9.66M
Consolidated Net Income 0.10M2.33M5.70M-0.01M-0.10M-1.08M-7.77M-9.18M0.77M-11.01M8.41M-9.24M-15.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-18.58M-3.49M-3.74M67.07M
Income towards Parent Company 0.10M2.33M5.70M-0.01M-0.10M-1.08M-7.77M-9.18M0.77M-11.01M8.41M-9.24M-15.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-18.58M-3.49M-3.74M67.07M
Net Income towards Common Stockholders 0.10M2.33M5.70M-0.01M-0.10M-1.08M-7.77M-9.18M0.77M-11.01M8.41M-9.24M-15.41M-10.19M-12.23M0.29M-33.94M-4.23M-11.33M3.67M-18.58M-3.49M-3.74M67.07M
Additional items
EPS (Basic) 0.000.190.62-0.050.00-0.16-0.47-0.210.01-0.160.11-0.13-0.22-0.14-0.170.00-0.46-0.06-0.15-0.07-0.24-0.04-0.050.70
EPS (Weighted Average and Diluted) 0.000.00-0.16-0.47-0.210.01-0.160.10-0.13-0.22-0.14-0.170.00-0.46-0.06-0.15-0.07-0.24-0.04-0.050.70
Shares Outstanding (Weighted Average) 25.14M8.03M8.19M25.21M25.21M9.69M26.10M51.57M42.88M69.76M70.77M71.05M71.47M71.24M71.99M73.17M74.14M73.52M75.80M77.60M78.04M77.50M79.89M81.30M82.45M
Shares Outstanding (Diluted Average) 25.14M25.21M26.10M51.57M42.88M77.68M70.77M78.50M71.47M71.24M71.99M73.17M81.01M73.52M75.80M77.60M78.04M77.50M79.89M81.30M82.45M
EBITDA -0.04M-0.90M-0.15M-1.48M-0.16M-4.22M-7.77M-9.73M-10.54M-13.69M-9.73M-10.43M-19.68M-12.83M-12.21M-7.45M-35.63M-9.87M-12.15M-7.09M-17.30M-7.58M-4.95M-5.62M
Tax Rate 21.00%8.21%2.60%21.00%21.00%28.40%-16.44%-0.61%5.10%1.89%2.98%30.86%2.93%1.95%-0.46%1.35%0.48%-0.56%